This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.
Rank the most well-adapted cancer treatments
Bionov™ provides a scored and ranked listing of the most well-adapted personalized medicine treatment options. The comprehensive analysis considers commonly used treatments, as well as targeted therapy, immunotherapy, hormone therapy, and newly approved oncology drugs. These options are presented either alone (monotherapy) or in combinations of up to 4 drugs.
Filter out therapies that are expected to have poor outcomes
Many cancer treatments are ineffective and can lead to drug resistance, added cost, and side-effects. Bionov™ can rank therapies against its databases of genes, pathways, and drug characteristics to predict which therapies are associated with improved outcomes.
Input your own combination therapy options
Combination therapy has been used widely to treat other diseases such as HIV/AIDS, and recent studies have shown it to be effective in cancer. However, its adoption has been limited in cancer in a large part due to its complexity. Bionov™ allows you to see where your own proposed combinations rank alongside other highly ranked options.
Bionov™ performs the multi-parametric analyses required to analyze millions of combination options.
Bionov™ platform incorporates custom curated databases of publications, clinical trials, genes, pathways, and drug characteristics.
Bionov™ looks at a patient’s mutations together rather than individually, such that it can analyze options that target multiple mutations rather than single drug therapies targeting individual mutations.
Bionov™ integration spans many types of biological data.
Bionov™ is agnostic to tumor profiling company data.
The Bionov™ approach has been used on thousands of patients since its initial development at the UC San Diego Moores Cancer Center and San Diego Supercomputer Center. Some recent Case Studies are provided.
The Bionov™ approach has been built upon a foundation of discoveries in oncology, genomics, molecular biology, and many other cross-disciplinary fields. Key Publications are provided.